Methscopolamine Bromide Tablet
Product Images NDC 43063-740

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methscopolamine Bromide (NDC 43063-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063740 Label (43063740)

This is a description of a medication called Methscopolamine Bromide, USP available in tablet form in a container with 100 tablets. Each tablet contains 2.5 mg of the medication for oral administration. The medication is controlled and requires a doctor's prescription. The text mentions the NDC # 43063-740-01 and side effects. The manufacturer is Bayshore Pharmaceuticals LLC, located in Short Hills, NJ, and the medication is packaged by them. No further information is available.*

FDA Label Image

Figure Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.